Cargando…

Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease

BACKGROUND: Hyperhomocysteinemia is considered an independent risk factor for cognitive impairment. OBJECTIVE: To study the correlation between homocysteine levels and cognitive impairment in patients with PD. METHODS: We conducted a case–control study that included 246 patients with PD, of whom 32...

Descripción completa

Detalles Bibliográficos
Autores principales:	Periñán, María Teresa, Macías-García, Daniel, Jesús, Silvia, Martín-Rodríguez, Juan Francisco, Muñoz-Delgado, Laura, Jimenez-Jaraba, Maria Valle, Buiza-Rueda, Dolores, Bonilla-Toribio, Marta, Adarmes-Gómez, Astrid Daniela, Gómez-Garre, Pilar, Mir, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813118/ https://www.ncbi.nlm.nih.gov/pubmed/36169739 http://dx.doi.org/10.1007/s00415-022-11361-y

Ejemplares similares

Serum lipid profile among sporadic and familial forms of Parkinson’s disease
por: Macías-García, Daniel, et al.
Publicado: (2021)

Peripheral inflammatory immune response differs among sporadic and familial Parkinson’s disease
por: Muñoz-Delgado, Laura, et al.
Publicado: (2023)

Author Correction: Peripheral inflammatory immune response differs among sporadic and familial Parkinson’s disease
por: Muñoz-Delgado, Laura, et al.
Publicado: (2023)

TMEM230 in Parkinson’s disease in a southern Spanish population
por: Tejera-Parrado, Cristina, et al.
Publicado: (2018)

A genetic analysis of a Spanish population with early onset Parkinson’s disease
por: Cristina, Tejera-Parrado, et al.
Publicado: (2020)

Transcriptomic analysis reveals an association of FCGBP with Parkinson’s disease
por: Gómez-Garre, Pilar, et al.
Publicado: (2022)

Effect Modification between Genes and Environment and Parkinson's Disease Risk
por: Periñán, Maria Teresa, et al.
Publicado: (2022)

GBA Variants Influence Motor and Non-Motor Features of Parkinson’s Disease
por: Jesús, Silvia, et al.
Publicado: (2016)

Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease
por: Huertas, Ismael, et al.
Publicado: (2017)

Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients
por: Baldelli, Luca, et al.
Publicado: (2021)

NR4A2 Mutations Can Cause Intellectual Disability and Language Impairment With Persistent Dystonia-Parkinsonism
por: Jesús, Silvia, et al.
Publicado: (2021)

Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients
por: Zago, Elisa, et al.
Publicado: (2022)

Homocysteine Levels in Parkinson's Disease: Is Entacapone Effective?
por: Kocer, Bilge, et al.
Publicado: (2016)

Role of homocysteine in the development and progression of Parkinson’s disease
por: Fan, Xiaoyan, et al.
Publicado: (2020)

Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype
por: Huertas, Ismael, et al.
Publicado: (2017)

The Combination of Homocysteine and C-Reactive Protein Predicts the Outcomes of Chinese Patients with Parkinson's Disease and Vascular Parkinsonism
por: Zhang, Limin, et al.
Publicado: (2011)

Progresses in signal and background modelling and recent measurements of background processes
por: Cueto Gomez, Ana Rosario
Publicado: (2022)

Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease
por: Sleeman, Isobel, et al.
Publicado: (2019)

A Ubiquitous NFC Solution for the Development of Tailored Marketing Strategies Based on Discount Vouchers and Loyalty Cards
por: Borrego-Jaraba, Francisco, et al.
Publicado: (2013)

PTPA variants and the risk for Parkinson’s disease in diverse ancestry populations
por: Ostrožovičová, Miriam, et al.
Publicado: (2023)

Elevation of Plasma Homocysteine and Minor Hallucinations in Parkinson's Disease: A Cross-Sectional Study
por: Zhong, Min, et al.
Publicado: (2022)

Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage
por: Zou, Jing, et al.
Publicado: (2018)

The homocysteine controversy
por: Smulders, Yvo M., et al.
Publicado: (2010)

Homocysteine and psoriasis
por: Lin, Xiran, et al.
Publicado: (2019)

Homocysteine and Glaucoma
por: Washington, Joshua, et al.
Publicado: (2023)

B Vitamins, Homocysteine and Bone Health
por: Fratoni, Valentina, et al.
Publicado: (2015)

The diagnostic value of pleural fluid homocysteine in malignant pleural effusion
por: Santotoribio, Jose D., et al.
Publicado: (2019)

Validation of a simple screening tool for early diagnosis of advanced Parkinson’s disease in daily practice: the CDEPA questionnaire
por: Martinez-Martin, Pablo, et al.
Publicado: (2018)

Serum Homocysteine Level in Parkinson's Disease and Its Association with Duration, Cardinal Manifestation, and Severity of Disease
por: Saadat, Payam, et al.
Publicado: (2018)

Serum B12, Homocysteine Levels, and their Effect on Peripheral Neuropathy in Parkinson's Disease: Indian Cohort
por: Mathukumalli, Neeharika L., et al.
Publicado: (2020)

Sex Differences in the Level of Homocysteine in Alzheimer’s Disease and Parkinson’s Disease Patients: A Meta-Analysis
por: Nguyen, V. Phu, et al.
Publicado: (2023)

Novel Bread Wheat Lines Enriched in Carotenoids Carrying Hordeum chilense Chromosome Arms in the ph1b Background
por: Rey, María-Dolores, et al.
Publicado: (2015)

Homocysteine Homeostasis and Betaine-Homocysteine S-Methyltransferase Expression in the Brain of Hibernating Bats
por: Zhang, Yijian, et al.
Publicado: (2013)

Reduced Immunosenescence of Peripheral Blood T Cells in Parkinson’s Disease with CMV Infection Background
por: Vavilova, Julia D., et al.
Publicado: (2021)

Homocysteine as a Predictor Tool in Multiple Sclerosis
por: Mititelu, Radu Razvan, et al.
Publicado: (2021)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Homocysteine and masked hypertension
por: Joob, Beuy, et al.
Publicado: (2015)

Homocysteine Intracerebroventricular Injection Induces Apoptosis in the Substantia Nigra Cells and Parkinson's Disease LikeBehavior in Rats
por: Ataie, Amin, et al.
Publicado: (2013)

Application of Periventricular White Matter Hyperintensities Combined with Homocysteine into Predicting Mild Cognitive Impairment in Parkinson’s Disease
por: Zhang, Zuowen, et al.
Publicado: (2023)

Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease
por: Martín-Bastida, Antonio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ku02pcfo5tkvcl9di3488am6fd